IMCSzyme®, a genetically modified beta-glucuronidase, is a patent pending enzyme solution mainly used to hydrolyze glucuronides obtained from biological fluids detecting a wide range of drugs. After hydrolysis with IMCSzyme, samples can be analyzed by enzyme immunoassay, mass spectrometry, high performance liquid chromatography and other means.
The accuracy of IMCSzyme has been tested on real patient samples in hundreds of labs. Our product has been featured in poster presentations at AACC, MSACL, SOFT, AAFS, ASMS and published in the Journal of Analytical Toxicology.
Includes Rapid Hydrolysis Buffer (20 mL)